Chest X-ray is the Most Important Initial Investigation
The best initial investigation for this patient is a chest X-ray to evaluate for pulmonary sarcoidosis, which classically presents with this exact constellation of findings: cough, fever, ankle arthritis (often asymmetric monoarthritis), erythema nodosum (tender red leg lesions), and elevated ESR with normal CBC 1, 2.
Clinical Syndrome Recognition
This patient presents with Löfgren syndrome, a distinct acute presentation of sarcoidosis characterized by:
- Erythema nodosum (tender red lesions on legs) 1, 2
- Bilateral hilar lymphadenopathy (causing irritable cough) 1
- Arthritis (commonly ankle, often asymmetric) 3, 2
- Fever and constitutional symptoms 1, 2
- Markedly elevated ESR (67 mm/hr indicates moderate elevation, consistent with active inflammation) 1
The normal CBC helps exclude hematologic causes and infectious processes that would typically show leukocytosis 3, 2.
Diagnostic Algorithm
First-Line Investigation
- Chest X-ray is the critical initial test to identify bilateral hilar lymphadenopathy, which is pathognomonic for Löfgren syndrome when combined with erythema nodosum and arthritis 1, 2
- This single test can establish the diagnosis without need for tissue biopsy in classic presentations 1
Essential Baseline Laboratory Panel
While imaging is most important, concurrent laboratory evaluation should include 3, 2:
- Complete blood count with differential (already done, normal)
- Comprehensive metabolic panel including liver enzymes and renal function 2
- Urinalysis 3
- Serum calcium (hypercalcemia occurs in sarcoidosis) 2
Additional Testing Based on Chest X-ray Results
If chest X-ray confirms bilateral hilar lymphadenopathy 1, 2:
- Serum angiotensin-converting enzyme (ACE) level supports diagnosis but is not specific
- Tuberculin skin test or interferon-gamma release assay to exclude tuberculosis
- Tissue biopsy is typically not required in classic Löfgren syndrome with characteristic imaging
If chest X-ray is normal, consider alternative diagnoses 3, 2:
- Rheumatoid factor and anti-CCP antibodies for inflammatory arthritis 3
- Antinuclear antibodies to exclude connective tissue disease 3
- Blood cultures if infectious etiology suspected 2
Why Other Investigations Are Less Appropriate Initially
ESR/CRP Monitoring
- ESR is already elevated at 67 mm/hr, confirming active inflammation 1
- Repeating inflammatory markers without identifying the underlying cause provides no diagnostic value 1, 4
- ESR and CRP lack specificity and cannot differentiate between causes 4, 5
Autoimmune Serologies Without Imaging
- Ordering rheumatologic panels (RF, anti-CCP, ANA) before chest imaging misses the most likely diagnosis 3
- These tests have limited utility when the clinical picture strongly suggests sarcoidosis 3, 6
- Up to 30-40% of inflammatory arthritis patients have negative serologies, making them unreliable as initial screening 6
Joint Aspiration
- While monoarthritis warrants consideration of septic arthritis, the presence of erythema nodosum, fever, and cough points to systemic disease rather than isolated joint infection 3, 7
- Joint aspiration is most indicated when infection is the primary concern 7
Critical Pitfalls to Avoid
- Do not delay chest imaging in patients with this classic triad—missing bilateral hilar lymphadenopathy delays diagnosis and appropriate management 1, 2
- Do not assume elevated ESR always requires extensive autoimmune workup—the clinical context (erythema nodosum + arthritis + respiratory symptoms) should guide investigation 1, 2
- Do not interpret normal CBC as excluding significant disease—sarcoidosis typically presents with normal or only mildly abnormal blood counts 8
- Recognize that ESR of 67 mm/hr is moderately elevated (50-100 mm/hr range) and indicates significant underlying disease requiring prompt diagnosis 1
Prognosis and Management Implications
Löfgren syndrome has an excellent prognosis with spontaneous resolution in most cases 1. Early identification through chest X-ray allows:
- Appropriate counseling about favorable outcomes
- Targeted symptomatic treatment with NSAIDs or short-course corticosteroids 3
- Avoidance of unnecessary immunosuppressive therapy
- Monitoring for the minority who develop chronic sarcoidosis